Brief: Paion Closes Enrollment In EU Phase III Trial With Remimazolam In General Anesthesia

PAION AG

02/04/2020 12:02

April 2 (Reuters) - PAION AG  PA8G.DE :
    * PAION CLOSES ENROLLMENT IN EU PHASE III TRIAL WITH
REMIMAZOLAM
IN GENERAL ANESTHESIA
    * TOPLINE STUDY RESULTS EXPECTED IN H2 2020, TIMELINE FOR
MAA
SUBMISSION CONFIRMED
    * 424 PATIENTS HAVE BEEN ENROLLED REPRESENTING A SUFFICIENT
NUMBER
TO CONDUCT PLANNED STATISTICAL ANALYSES
    * DATA MONITORING COMMITTEE HAS AGREED TO CLOSE TRIAL WITH
CURRENT
NUMBER OF PATIENTS

Source text for Eikon:  ID:nEQ3bMLySa 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))